Constriction, Pathologic: Clinical Trials

15 trials for Constriction, Pathologic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 3 terminated, 3 unknown, 2 recruiting. 15 Phase 3, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 315Completed 5, Terminated 3, Unknown 3, Recruiting 2, Not yet recruiting 1, Withdrawn 1
Phase 24Unknown 2, Completed 1, Not yet recruiting 1

Follow Constriction, Pathologic: new trials by email Literature Review of Constriction, Pathologic trials Research Report on Constriction, Pathologic

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Adjuvant Steroid Outcomes in Idiopathic Subglottic Stenosis
Triamcinolone 0.1%, Placebo - Idiopathic Subglottic Stenosis
Phase 3RecruitingJohns Hopkins University2262026-05-202026-10-22
A Study Comparing the MAGICTouch™ Sirolimus-coated Balloon With a Paclitaxel-coated Balloon for Treating Severe Narrowing or Blockage in the Femoropopliteal Arteries.
Sirolimus (RAPAMUNE) drug-coated balloon angioplasty catheter, Paclitaxel drug-coated balloon angioplasty - Popliteal Artery Disease, Superficial Femoral Artery Disease
Phase 2 / Phase 3Not yet recruitingConcept Medical Inc.4782026-04-012026-04-17
Anticoagulation Using Rivaroxaban on Top of Aspirin in Intracranial Atherosclerotic Stenosis
Rivaroxaban, Clopidogrel, Aspirin - Ischemic Stroke, Intracranial Atherosclerosis
Phase 2 / Phase 3UnknownThe First Affiliated Hospital with Nanjing Medical University11802023-12-302023-12-21
Extra Alirocumab in Addition to Statin Therapy in Asymptomatic Intracranial Atherosclerotic Stenosis (EAST-aICAS)
Alirocumab, Atorvastatin - Intracranial Atherosclerosis, Atherosclerotic Plaque
Phase 3UnknownThe First Affiliated Hospital with Nanjing Medical University802023-12-302023-12-21
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
GIE Medical ProTractX3 TTS DCB, Control - Bowel; Stricture
Phase 3RecruitingGIE Medical1712023-11-012025-06-25
Impact of Local Steroid Application in Extreme Lateral Lumbar Interbody Fusion
Methylprednisolone, Saline - Stenosis, Herniated Nucleus Pulposus
Phase 3WithdrawnRush University Medical Center2018-05-222020-11-20
Colchicine to Prevent Post-Pericardiotomy Syndrome and Atrial Fibrillation
Colchicine, Placebo - Atrial Fibrillation, Post-pericardiotomy Syndrome
Phase 3TerminatedMayo Clinic22015-05-012017-06-21
Clinical Trial on Peripheral Arteries Treated With SeQuent® Please P Paclitaxel Coated Balloon Catheter
Paclitaxel coated balloon, uncoated PTA catheter - Stenosis, Restenosis
Phase 3CompletedB. Braun Melsungen AG1532013-10-012020-03-30
Comparison of Endoscopic Radiofrequency Ablation Versus Photodynamic Therapy for Inoperable Cholangiocarcinoma
Self expanding metallic stent (SEMS), Endoscopic radiofrequency ablation (ERFA), Photodynamic therapy (PDT) - Cholangiocarcinoma
Phase 2 / Phase 3UnknownGuangzhou Medical University1202012-11-012013-02-26
ViVEXX Carotid Revascularization Trial (VIVA)
Carotid Artery Stenting - Carotid Artery Stenosis
Phase 3CompletedC. R. Bard4072005-10-012017-03-01
BBC ONE - British Bifurcation Coronary Study
Coronary Angioplasty - Ischaemic Heart Diseases, Stenosis
Phase 3CompletedRoyal Sussex County Hospital5002005-01-012008-04-16
Abciximab for Prevention of Stroke Recurrence Before Endarterectomy in Symptomatic Carotid Stenosis
Abciximab - Stroke, Stenosis
Phase 3TerminatedUniversity of Zurich1002004-04-012007-05-03
Magnevist® Injection Enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis in the Calf and/or Pedal Arteries
Gadopentetate dimeglumine (Magnevist) - Stenosis
Phase 3CompletedBayer1262003-12-012014-12-30
Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stents to Treat De Novo Coronary Lesions
TAXUS Paclitaxel-Eluting Coronary Stent, Slow-Formulation, Express2 - Coronary Stenosis
Phase 2 / Phase 3CompletedBoston Scientific Corporation11082003-02-012010-08-06
Aspirin Or Warfarin To Prevent Stroke
Warfarin, Aspirin - Stroke, Cerebral Infarction
Phase 3TerminatedNational Institute of Neurological Disorders and Stroke (NINDS)2006-06-06

Narrower conditions

Stroke (3)  ·  Carotid Stenosis (2)  ·  Intracranial Arteriosclerosis (2)  ·  Ischemic Stroke (2)  ·  Adenocarcinoma (1)  ·  Angina Pectoris (1)  ·  Atherosclerosis (1)  ·  Atrial Fibrillation (1)  ·  Bile Duct Diseases (1)  ·  Biliary Tract Diseases (1)  ·  Bites and Stings (1)  ·  Carcinoma (1)  ·  Cerebral Infarction (1)  ·  Cholangiocarcinoma (1)

Broader conditions

Pathological Conditions, Anatomical (15)  ·  Pathological Conditions, Signs and Symptoms (15)  ·  Cardiovascular Diseases (9)  ·  Vascular Diseases (8)  ·  Arterial Occlusive Diseases (7)  ·  Nervous System Diseases (7)  ·  Central Nervous System Diseases (6)  ·  Arteriosclerosis (5)  ·  Brain Diseases (5)  ·  Cerebrovascular Disorders (5)  ·  Heart Diseases (3)  ·  Carotid Artery Diseases (2)  ·  Coronary Disease (2)  ·  Intracranial Arterial Diseases (2)  ·  Myocardial Ischemia (2)

Interventions

Aspirin (2)  ·  Abciximab (1)  ·  Angioplasty, Balloon (1)  ·  Atorvastatin (1)  ·  Clopidogrel (1)  ·  Colchicine (1)  ·  Gadolinium DTPA (1)  ·  Methylprednisolone (1)  ·  Photochemotherapy (1)  ·  Rivaroxaban (1)  ·  Sirolimus (1)  ·  Sodium Chloride (1)  ·  Warfarin (1)  ·  alirocumab (1)

Sponsors

The First Affiliated Hospital with Nanjing Medical University (2)  ·  B. Braun Melsungen AG (1)  ·  Bayer (1)  ·  Boston Scientific Corporation (1)  ·  C. R. Bard (1)  ·  Concept Medical Inc. (1)  ·  GIE Medical (1)  ·  Guangzhou Medical University (1)  ·  Johns Hopkins University (1)  ·  Mayo Clinic (1)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (1)  ·  Royal Sussex County Hospital (1)  ·  Rush University Medical Center (1)  ·  University of Zurich (1)

Countries

United States (6)  ·  China (2)  ·  Germany (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Alexander Hillel, MD (1)  ·  Brain DeRubertis, MD (1)  ·  David J.R, Hildick-Smith, MD (1)  ·  Edward Choke, PhD (1)  ·  Eric A Secemsky, MD (1)  ·  Farhana Siddique (1)  ·  Gregg W. Stone, MD (1)  ·  Jae Oh, MD (1)  ·  Kenneth Rosenfield, MD (1)  ·  Kern Singh, MD (1)  ·  Kezhong Zhang, Doctor (1)  ·  Kezhong Zhang, MD (1)  ·  Marc Chimowitz (1)  ·  Masahiko Fujihara, MD (1)

Results publications

PMID 16160130, PMID 20129555, PMID 20194880, PMID 21205942, PMID 22496083, PMID 27161619, PMID 28660441, PMID 29589098, PMID 39182330, PMID 42573020

NIH funding

1UG3HL173394-01A1 (1)